Torii Pharmaceutical Co., Ltd. (TRXPF)
TRXPF Stock Price Chart
Explore Torii Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze TRXPF price movements and trends.
TRXPF Company Profile
Discover essential business fundamentals and corporate details for Torii Pharmaceutical Co., Ltd. (TRXPF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
15 Mar 2013
Employees
583.00
Website
https://www.torii.co.jpCEO
Goichi Matsuda
Description
Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.
TRXPF Financial Timeline
Browse a chronological timeline of Torii Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Stock split effective on 28 Aug 2025
Shares were split 1 : 1924850 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 31 Jul 2025
EPS came in at $0.30 , while revenue for the quarter reached $115.85M .
Dividend declared on 27 Jun 2025
A dividend of $0.41 per share was announced, adjusted to $0.41. The dividend was paid on 1 Sept 2025.
Earnings released on 25 Apr 2025
EPS came in at $0.33 , while revenue for the quarter reached $97.88M .
Earnings released on 7 Feb 2025
EPS came in at $0.34 , while revenue for the quarter reached $108.71M .
Dividend declared on 27 Dec 2024
A dividend of $0.41 per share was announced, adjusted to $0.41. The dividend was paid on 28 Mar 2025.
Earnings released on 31 Oct 2024
EPS came in at $46.39 , while revenue for the quarter reached $15.02B .
Earnings released on 31 Jul 2024
EPS came in at $47.78 , while revenue for the quarter reached $14.86B .
Earnings released on 26 Apr 2024
EPS came in at $31.24 , while revenue for the quarter reached $13.45B .
Earnings released on 9 Feb 2024
EPS came in at $62.30 , while revenue for the quarter reached $15.51B .
Dividend declared on 9 Feb 2024
A dividend of $0.38 per share was announced, adjusted to $0.38. The dividend was paid on 28 Mar 2025.
Dividend declared on 9 Feb 2024
A dividend of $60.00 per share was announced, adjusted to $0.41. The dividend was paid on 4 Sept 2024.
Earnings released on 30 Sept 2023
EPS came in at $45.61 , while revenue for the quarter reached $13.43B .
Earnings released on 30 Jun 2023
EPS came in at $48.89 , while revenue for the quarter reached $13.89B .
Earnings released on 31 Mar 2023
EPS came in at -$10.29 , while revenue for the quarter reached $11.81B .
Earnings released on 10 Feb 2023
EPS came in at $38.72 , while revenue for the quarter reached $13.58B .
Dividend declared on 10 Feb 2023
A dividend of $0.50 per share was announced, adjusted to $0.47. The dividend was paid on 28 Mar 2024.
Dividend declared on 10 Feb 2023
A dividend of $0.35 per share was announced, adjusted to $0.34. The dividend was paid on 5 Sept 2023.
Earnings released on 31 Oct 2022
EPS came in at $9.39 , while revenue for the quarter reached $12.21B .
Earnings released on 29 Jul 2022
EPS came in at $8.95 , while revenue for the quarter reached $12.14B .
Earnings released on 28 Apr 2022
EPS came in at $31.40 , while revenue for the quarter reached $10.96B .
Earnings released on 10 Feb 2022
EPS came in at $10.56 , while revenue for the quarter reached $13.55B .
Dividend declared on 10 Feb 2022
A dividend of $0.58 per share was announced, adjusted to $0.52. The dividend was paid on 29 Mar 2023.
Dividend declared on 10 Feb 2022
A dividend of $0.18 per share was announced, adjusted to $0.16. The dividend was paid on 2 Sept 2022.
Earnings released on 29 Oct 2021
EPS came in at $35.39 , while revenue for the quarter reached $11.88B .
Earnings released on 30 Jul 2021
EPS came in at $28.77 , while revenue for the quarter reached $11.66B .
Earnings released on 28 Apr 2021
EPS came in at $15.52 , while revenue for the quarter reached $9.90B .
Earnings released on 4 Feb 2021
EPS came in at $35.14 , while revenue for the quarter reached $11.53B .
Dividend declared on 4 Feb 2021
A dividend of $0.21 per share was announced, adjusted to $0.16. The dividend was paid on 30 Mar 2022.
Dividend declared on 4 Feb 2021
A dividend of $0.22 per share was announced, adjusted to $0.16. The dividend was paid on 3 Sept 2021.
Earnings released on 30 Oct 2020
EPS came in at $25.21 , while revenue for the quarter reached $10.32B .
Dividend declared on 6 Feb 2020
A dividend of $0.23 per share was announced, adjusted to $0.16. The dividend was paid on 26 Mar 2021.
TRXPF Stock Performance
Access detailed TRXPF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.